世界の末期腎疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global End Stage Renal Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4184 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、末期腎疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（移植、透析）、用途別市場規模（公立病院、私立病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・末期腎疾患治療の市場動向 ・企業の競争状況、市場シェア ・末期腎疾患治療の種類別市場規模と予測2016-2027（移植、透析） ・末期腎疾患治療の用途別市場規模と予測2016-2027（公立病院、私立病院） ・末期腎疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・末期腎疾患治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・末期腎疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・末期腎疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・末期腎疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Nipro Corporation、Fresenius Medical Care、Baxter International, Inc.、Medtronic、B. Braun Melsungen AG、BD、Asahi Kasei Medical Co., Ltd.、Cantel Medical、Nikkiso、JMS） ・結論

Any condition that causes reduced kidney function leads to chronic kidney disease (CKD), which may develop over a period and lead to end stage renal disease (ESRD), where kidney can no longer function on their own. It is also termed as kidney or renal failure. Factors contributing to the formation of end stage renal disease include hypertension, diabetes, smoking, and older age. The most common cause is diabetes, whereas hypertension (high blood pressure) is the second most frequent cause of end stage kidney disease. The treatment of end stage renal disease or CKD includes kidney transplantation or dialysis to stay alive.

Market Analysis and Insights: Global End Stage Renal Disease Treatment Market
The global End Stage Renal Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global End Stage Renal Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global End Stage Renal Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global End Stage Renal Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global End Stage Renal Disease Treatment market.

Global End Stage Renal Disease Treatment Scope and Market Size
End Stage Renal Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global End Stage Renal Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Transplantation
Dialysis

Segment by Application
Public Hospitals
Private Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso
JMS

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transplantation
1.2.3 Dialysis
1.3 Market by Application
1.3.1 Global End Stage Renal Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Public Hospitals
1.3.3 Private Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global End Stage Renal Disease Treatment Market Perspective (2016-2027)
2.2 End Stage Renal Disease Treatment Growth Trends by Regions
2.2.1 End Stage Renal Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 End Stage Renal Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 End Stage Renal Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 End Stage Renal Disease Treatment Industry Dynamic
2.3.1 End Stage Renal Disease Treatment Market Trends
2.3.2 End Stage Renal Disease Treatment Market Drivers
2.3.3 End Stage Renal Disease Treatment Market Challenges
2.3.4 End Stage Renal Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease Treatment Players by Revenue
3.1.1 Global Top End Stage Renal Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global End Stage Renal Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by End Stage Renal Disease Treatment Revenue
3.4 Global End Stage Renal Disease Treatment Market Concentration Ratio
3.4.1 Global End Stage Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease Treatment Revenue in 2020
3.5 End Stage Renal Disease Treatment Key Players Head office and Area Served
3.6 Key Players End Stage Renal Disease Treatment Product Solution and Service
3.7 Date of Enter into End Stage Renal Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 End Stage Renal Disease Treatment Breakdown Data by Type
4.1 Global End Stage Renal Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2022-2027)

5 End Stage Renal Disease Treatment Breakdown Data by Application
5.1 Global End Stage Renal Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America End Stage Renal Disease Treatment Market Size (2016-2027)
6.2 North America End Stage Renal Disease Treatment Market Size by Type
6.2.1 North America End Stage Renal Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America End Stage Renal Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America End Stage Renal Disease Treatment Market Size by Type (2016-2027)
6.3 North America End Stage Renal Disease Treatment Market Size by Application
6.3.1 North America End Stage Renal Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America End Stage Renal Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America End Stage Renal Disease Treatment Market Size by Application (2016-2027)
6.4 North America End Stage Renal Disease Treatment Market Size by Country
6.4.1 North America End Stage Renal Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America End Stage Renal Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe End Stage Renal Disease Treatment Market Size (2016-2027)
7.2 Europe End Stage Renal Disease Treatment Market Size by Type
7.2.1 Europe End Stage Renal Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe End Stage Renal Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe End Stage Renal Disease Treatment Market Size by Type (2016-2027)
7.3 Europe End Stage Renal Disease Treatment Market Size by Application
7.3.1 Europe End Stage Renal Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe End Stage Renal Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe End Stage Renal Disease Treatment Market Size by Application (2016-2027)
7.4 Europe End Stage Renal Disease Treatment Market Size by Country
7.4.1 Europe End Stage Renal Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe End Stage Renal Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific End Stage Renal Disease Treatment Market Size by Type
8.2.1 Asia-Pacific End Stage Renal Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific End Stage Renal Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Application
8.3.1 Asia-Pacific End Stage Renal Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific End Stage Renal Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region
8.4.1 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America End Stage Renal Disease Treatment Market Size (2016-2027)
9.2 Latin America End Stage Renal Disease Treatment Market Size by Type
9.2.1 Latin America End Stage Renal Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America End Stage Renal Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America End Stage Renal Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America End Stage Renal Disease Treatment Market Size by Application
9.3.1 Latin America End Stage Renal Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America End Stage Renal Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America End Stage Renal Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America End Stage Renal Disease Treatment Market Size by Country
9.4.1 Latin America End Stage Renal Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America End Stage Renal Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa End Stage Renal Disease Treatment Market Size by Type
10.2.1 Middle East & Africa End Stage Renal Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa End Stage Renal Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Application
10.3.1 Middle East & Africa End Stage Renal Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa End Stage Renal Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country
10.4.1 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Nipro Corporation
11.1.1 Nipro Corporation Company Details
11.1.2 Nipro Corporation Business Overview
11.1.3 Nipro Corporation End Stage Renal Disease Treatment Introduction
11.1.4 Nipro Corporation Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.1.5 Nipro Corporation Recent Development
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Details
11.2.2 Fresenius Medical Care Business Overview
11.2.3 Fresenius Medical Care End Stage Renal Disease Treatment Introduction
11.2.4 Fresenius Medical Care Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.2.5 Fresenius Medical Care Recent Development
11.3 Baxter International, Inc.
11.3.1 Baxter International, Inc. Company Details
11.3.2 Baxter International, Inc. Business Overview
11.3.3 Baxter International, Inc. End Stage Renal Disease Treatment Introduction
11.3.4 Baxter International, Inc. Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.3.5 Baxter International, Inc. Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic End Stage Renal Disease Treatment Introduction
11.4.4 Medtronic Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.4.5 Medtronic Recent Development
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Details
11.5.2 B. Braun Melsungen AG Business Overview
11.5.3 B. Braun Melsungen AG End Stage Renal Disease Treatment Introduction
11.5.4 B. Braun Melsungen AG Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.5.5 B. Braun Melsungen AG Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD End Stage Renal Disease Treatment Introduction
11.6.4 BD Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.6.5 BD Recent Development
11.7 Asahi Kasei Medical Co., Ltd.
11.7.1 Asahi Kasei Medical Co., Ltd. Company Details
11.7.2 Asahi Kasei Medical Co., Ltd. Business Overview
11.7.3 Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Introduction
11.7.4 Asahi Kasei Medical Co., Ltd. Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.7.5 Asahi Kasei Medical Co., Ltd. Recent Development
11.8 Cantel Medical
11.8.1 Cantel Medical Company Details
11.8.2 Cantel Medical Business Overview
11.8.3 Cantel Medical End Stage Renal Disease Treatment Introduction
11.8.4 Cantel Medical Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.8.5 Cantel Medical Recent Development
11.9 Nikkiso
11.9.1 Nikkiso Company Details
11.9.2 Nikkiso Business Overview
11.9.3 Nikkiso End Stage Renal Disease Treatment Introduction
11.9.4 Nikkiso Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.9.5 Nikkiso Recent Development
11.10 JMS
11.10.1 JMS Company Details
11.10.2 JMS Business Overview
11.10.3 JMS End Stage Renal Disease Treatment Introduction
11.10.4 JMS Revenue in End Stage Renal Disease Treatment Business (2016-2021)
11.10.5 JMS Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global End Stage Renal Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transplantation
Table 3. Key Players of Dialysis
Table 4. Global End Stage Renal Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global End Stage Renal Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global End Stage Renal Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global End Stage Renal Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global End Stage Renal Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global End Stage Renal Disease Treatment Market Share by Regions (2022-2027)
Table 10. End Stage Renal Disease Treatment Market Trends
Table 11. End Stage Renal Disease Treatment Market Drivers
Table 12. End Stage Renal Disease Treatment Market Challenges
Table 13. End Stage Renal Disease Treatment Market Restraints
Table 14. Global End Stage Renal Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global End Stage Renal Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top End Stage Renal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End Stage Renal Disease Treatment as of 2020)
Table 17. Ranking of Global Top End Stage Renal Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by End Stage Renal Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players End Stage Renal Disease Treatment Product Solution and Service
Table 21. Date of Enter into End Stage Renal Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global End Stage Renal Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global End Stage Renal Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America End Stage Renal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America End Stage Renal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America End Stage Renal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America End Stage Renal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America End Stage Renal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe End Stage Renal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe End Stage Renal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe End Stage Renal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe End Stage Renal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe End Stage Renal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific End Stage Renal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific End Stage Renal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific End Stage Renal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America End Stage Renal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America End Stage Renal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America End Stage Renal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America End Stage Renal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America End Stage Renal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa End Stage Renal Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa End Stage Renal Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa End Stage Renal Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa End Stage Renal Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Nipro Corporation Company Details
Table 62. Nipro Corporation Business Overview
Table 63. Nipro Corporation End Stage Renal Disease Treatment Product
Table 64. Nipro Corporation Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Nipro Corporation Recent Development
Table 66. Fresenius Medical Care Company Details
Table 67. Fresenius Medical Care Business Overview
Table 68. Fresenius Medical Care End Stage Renal Disease Treatment Product
Table 69. Fresenius Medical Care Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. Fresenius Medical Care Recent Development
Table 71. Baxter International, Inc. Company Details
Table 72. Baxter International, Inc. Business Overview
Table 73. Baxter International, Inc. End Stage Renal Disease Treatment Product
Table 74. Baxter International, Inc. Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Baxter International, Inc. Recent Development
Table 76. Medtronic Company Details
Table 77. Medtronic Business Overview
Table 78. Medtronic End Stage Renal Disease Treatment Product
Table 79. Medtronic Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Medtronic Recent Development
Table 81. B. Braun Melsungen AG Company Details
Table 82. B. Braun Melsungen AG Business Overview
Table 83. B. Braun Melsungen AG End Stage Renal Disease Treatment Product
Table 84. B. Braun Melsungen AG Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. B. Braun Melsungen AG Recent Development
Table 86. BD Company Details
Table 87. BD Business Overview
Table 88. BD End Stage Renal Disease Treatment Product
Table 89. BD Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. BD Recent Development
Table 91. Asahi Kasei Medical Co., Ltd. Company Details
Table 92. Asahi Kasei Medical Co., Ltd. Business Overview
Table 93. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Product
Table 94. Asahi Kasei Medical Co., Ltd. Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Asahi Kasei Medical Co., Ltd. Recent Development
Table 96. Cantel Medical Company Details
Table 97. Cantel Medical Business Overview
Table 98. Cantel Medical Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Cantel Medical Recent Development
Table 100. Nikkiso Company Details
Table 101. Nikkiso Business Overview
Table 102. Nikkiso End Stage Renal Disease Treatment Product
Table 103. Nikkiso Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 104. Nikkiso Recent Development
Table 105. JMS Company Details
Table 106. JMS Business Overview
Table 107. JMS End Stage Renal Disease Treatment Product
Table 108. JMS Revenue in End Stage Renal Disease Treatment Business (2016-2021) & (US$ Million)
Table 109. JMS Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global End Stage Renal Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Transplantation Features
Figure 3. Dialysis Features
Figure 4. Global End Stage Renal Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Public Hospitals Case Studies
Figure 6. Private Hospitals Case Studies
Figure 7. End Stage Renal Disease Treatment Report Years Considered
Figure 8. Global End Stage Renal Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global End Stage Renal Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global End Stage Renal Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global End Stage Renal Disease Treatment Market Share by Regions (2022-2027)
Figure 12. Global End Stage Renal Disease Treatment Market Share by Players in 2020
Figure 13. Global Top End Stage Renal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End Stage Renal Disease Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by End Stage Renal Disease Treatment Revenue in 2020
Figure 15. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global End Stage Renal Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America End Stage Renal Disease Treatment Market Share by Type (2016-2027)
Figure 19. North America End Stage Renal Disease Treatment Market Share by Application (2016-2027)
Figure 20. North America End Stage Renal Disease Treatment Market Share by Country (2016-2027)
Figure 21. United States End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe End Stage Renal Disease Treatment Market Share by Type (2016-2027)
Figure 25. Europe End Stage Renal Disease Treatment Market Share by Application (2016-2027)
Figure 26. Europe End Stage Renal Disease Treatment Market Share by Country (2016-2027)
Figure 27. Germany End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific End Stage Renal Disease Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific End Stage Renal Disease Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific End Stage Renal Disease Treatment Market Share by Region (2016-2027)
Figure 37. China End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America End Stage Renal Disease Treatment Market Share by Type (2016-2027)
Figure 45. Latin America End Stage Renal Disease Treatment Market Share by Application (2016-2027)
Figure 46. Latin America End Stage Renal Disease Treatment Market Share by Country (2016-2027)
Figure 47. Mexico End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa End Stage Renal Disease Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa End Stage Renal Disease Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa End Stage Renal Disease Treatment Market Share by Country (2016-2027)
Figure 53. Turkey End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE End Stage Renal Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Nipro Corporation Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 57. Fresenius Medical Care Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 58. Baxter International, Inc. Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 59. Medtronic Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 60. B. Braun Melsungen AG Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 61. BD Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 62. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 63. Cantel Medical Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 64. Nikkiso Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 65. JMS Revenue Growth Rate in End Stage Renal Disease Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---